DR. DOPING

Instructions

Logo DR. DOPING

Instructions / Instruction for use: Betnovate-C

I want this, give me price

Active substance Betamethasone + Salicylic acid

ATX code D07XC01 Betamethasone in combination with other drugs

Pharmacological group

Glucocorticosteroids in combinations

Composition and form of release

Betnovate®

Betnovate, cream for external use 100 g

Betamethasone valerate 0.12 g

Excipients: chlorocresol; Cetomacrogol 1000; Cetostearyl alcohol; Paraffin white soft; Paraffin liquid; Sodium phosphate disubstituted 12-water; Sodium phosphate monosubstituted dihydrate; Propylene glycol; Phosphoric acid or sodium hydroxide; water

In tubes of aluminum for 20 g; In a pack of cardboard 1 tuba.

Betnovate®-GM

Betnovate-GM, cream for external use 100 g

Betamethasone valerate 0.12 g

Gentamycin sulfate 0.178 g

Miconazole nitrate 2.04 g

Excipients: chlorocresol; Cetomacrogol 1000; Cetostearyl alcohol; Paraffin white soft; Paraffin liquid; Sodium citrate; Citric acid monohydrate; Propylene glycol; purified water

In tubes of aluminum for 20 g; In a pack of cardboard 1 tuba.

Betnovate®-C

Betnovate-C, ointment 100 g

Betamethasone valerate 0.12 g

Salicylic acid 3 g

Auxiliary substances: paraffin liquid; Paraffin white soft

In tubes of aluminum for 20 g; In a pack of cardboard 1 tuba.

Betnovate®-N

Betnovate-N, eye and ear drops 100 ml

Betamethasone sodium phosphate 0.1 g

Neomycin sulfate 0.5 g

Excipients: thiomersal; EDTA disodium; Sodium formate; Sodium hydroxide; Paraffin liquid; water for injections

In glass bottles of 5 ml; In a pack of cardboard 1 bottle with a sterile dropper.

pharmachologic effect

Pharmacological action - glucocorticoid.

Dosing and Administration

Betnovate®

Outwardly. A small amount of cream is applied to the affected parts of the body 2-3 times a day and gently rubbed. After the appearance of the effect, the frequency of applications is reduced to 1-2 times a day.

Children are prescribed 1 time per day.

In the case of pronounced hyperkeratosis (psoriatic plaques on the elbows and knees), the Betnovate effect can be enhanced by superimposing occlusive bandages on the affected areas with a polyethylene film (overnight only), and with the improvement of the condition, maintenance therapy is carried out by regular applications without bandages.

In the absence of regular medical supervision, treatment should not exceed 7 days.

In children and patients with skin lesions, treatment should not exceed 5 days.

Betnovate®-GM

Outwardly. A small amount of cream is applied to the affected areas of the body 2-3 times a day in adults until signs of improvement, after which it is possible to continue using the drug 1 time per day. Duration of treatment is determined individually and depends on the nosological form and severity of the disease.

Betnovate®-C

External, on the affected areas, lightly rubbing, apply a thin layer 2-3 times a day. If necessary, occlusive dressings are applied, which are changed every 24 hours (because of the delay in the evaporation of sweat and skin respiration, a moist chamber is created that facilitates loosening of the stratum corneum and accelerated, deeper penetration of the drug - about 100 times greater than when applied simply).

The course of treatment is up to 3 weeks. If necessary, prolonged treatment is less often used - every other day. In the treatment of chronic diseases, treatment should continue for some time after the disappearance of all symptoms to avoid recurrence of the disease.

Betnovate®-N

Locally. Eyes: 1 - 2 drops are instilled in the affected eye every 1 to 2 hours during the day and at intervals of 2 hours - during the night; When softening acute symptoms - 4-6 times a day.

Ears: 2-3 drops are instilled into the ear canal on the side of the lesion every 2-3 hours until signs of improvement appear, then the frequency of application can be reduced. In children older than 2 years, Betnovate-H can be used in the same doses as for adults, but with a lower frequency.

The course of treatment - no more than 7 days without supervision of the doctor.

In patients with renal insufficiency, the dose is reduced.

A comment

The drug is in the process of registration.

Storage conditions

At a temperature of 8-25 ° C.

Keep out of the reach of children.

Shelf life

Cream for external use 0.1% - 2 years.

Cream for external use - 2 years.

Ointment for external use - 2 years.

Drops eye and ear - 18 months.

Do not use after the expiry date printed on the package.